Analysis of morbid events and risk factors for death after cardiac transplantation

Journal of the American College of Cardiology

Volumn 11, Issue 5, 1988, Pages 917-924

  Kirklin, James K ^a   Naftel, David C ^a   McGlffin, David C ^a   McVay, Reba F ^a   Blackstone, Eugene H ^a   Karp, Robert B ^a  

^a UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; DEATH; FATALITY; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; INFECTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR; ACUTE DISEASE; ARTICLE; BACTERIAL INFECTION; COMPARATIVE STUDY; FOLLOW UP; HEART ARREST; MYOCARDIAL DISEASE; POSTOPERATIVE COMPLICATION; REOPERATION; SUDDEN DEATH; TIME; VASCULAR RESISTANCE;

AZATHIOPRINE; CYCLOSPORIN DERIVATIVE;

ACUTE DISEASE; AZATHIOPRINE; BACTERIAL INFECTIONS; COMPARATIVE STUDY; CYCLOSPORINS; DEATH, SUDDEN; FOLLOW-UP STUDIES; GRAFT REJECTION; HEART ARREST; HEART TRANSPLANTATION; HUMAN; MYOCARDIAL DISEASES; POSTOPERATIVE COMPLICATIONS; REOPERATION; RISK FACTORS; TIME FACTORS; VASCULAR RESISTANCE;

EID: 0023818521     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)90045-6     Document Type: Article

References (36)

1. Choice and handling of donors for cardiac transplantation
2. Coordination of cardiac transplantation: patient processing and donor organ procurement
3. Principles of multiple organ procurement from cadaver donors
4. Studies on orthotopic transplantation of the canine heart
5. Left ventricular bypass
6. The surgical technique of heterotopic heart transplantation
7. Arteritis in cardiac rejection after transplantation
8. Some recent advances in cardiac pathology
9. The decomposition of timevarying hazard into phase each incorporating a separate stream of concomitant information
10. Cardiac homotransplantation
11. Cardiac transplantation at the Texas Heart Institute: comparative analysis of 2 groups of patients (1968–1969 and 1982–1983)
12. A decade of human heart transplantation
13. Long-term survival and function after cardiac transplantation
14. Cardiac transplantation with cyclosporine: the Pillsburgh experience
15. Cardiac transplantation in patients over the age of 50 yeyrs
16. The cardiac donor: a six-year experience
17. Accelerated atherosclerosis in cardiac transplantation: role of cytotoxic B-cell antibodies and hyperlipidemia
18. Determinants of accelerated graft atherosclerosis (AGAS) in conventional and cyclosporine treated heart transplant recipients (abstr)
19. Selection of candidates for cardiac transplantation
20. The Registry of the International Society for Heart Transplantation: third official report—June
21. Enhanced myocardial protection during ischemic arrest
22. Reduction of postischemic myocardial damage by maintaining arrest during initial reperfusion
23. Accelerated myocardial metabolic recovery with terminal warm blood cardioplegia
24. The plight of the invasive treatment of ischemic heart disease
25. Determinants of operative risk in human heart transplantation
26. Patients with congestive cardiomyopathy as cardiac transplant recipients
27. A prospective, randomized trial of pretransfusion/azathioprine/ATG prednisone versus cyclosporine/prednisone immunosuppression in cardiac transplantation: progress report
28. Cartiac transplantation with cyclosporine A and prednisone
29. Reduction of infectious complicutions following heart transplantation with triple-drug immunotherapy
30. The behavior and late of skin autografts and skin homografts in rabbits
31. The cellular immune basis of cardiac allograft rejection
32. Treatment of moderate heart allograft rejection using cyclosporiue (abstr)
33. Reversal of cardiac transplant rejection without massive immunosuppression
34. Early infections in kidney, heart, and liver transplant recipients on cydosporine
35. Infections after cardiac transptantation: relation to rejection therapy